BIMEKIZUMAB: The First Dual Inhibitor of Interleukin (Il)-17A and Il-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis

AuthID
 P-00Q-PV1
3
Author(s)
Vender, R
·
Torres, T
Document Type
Review
Year published
2019
Published
in BIODRUGS, ISSN: 1173-8804
Volume: 33, Issue: 4, Pages: 391-399 (9)
Indexing
Wos®
Scopus®
Google Scholar®
Publication Identifiers
Scopus: 2-s2.0-85067068767
Wos: WOS:000476594900005
Source Identifiers
ISSN: 1173-8804
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service